Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cardiac radiotherapy–induced epigenetic memory underlies electrophysiologic and metabolic reprogramming
Samuel D. Jordan, Shuhua Fu, Abigail Fulkerson, Donghua Hu, Sherwin Ng, David M. Zhang, Sneha Manikandan, Jeffrey Szymanski, Nan Hu, Yuqian Xie, Anish Bedi, James Tabor, Lauren Boggs-Bailey, Lori Strong, Stephanie Hicks, Lavanya Aryan, Nishanth Gabriel, Geoffrey D. Hugo, Kuo-Chan Weng, Nathaniel Huebsch, Julie K. Schwarz, Bo Zhang, Stacey L. Rentschler
Samuel D. Jordan, Shuhua Fu, Abigail Fulkerson, Donghua Hu, Sherwin Ng, David M. Zhang, Sneha Manikandan, Jeffrey Szymanski, Nan Hu, Yuqian Xie, Anish Bedi, James Tabor, Lauren Boggs-Bailey, Lori Strong, Stephanie Hicks, Lavanya Aryan, Nishanth Gabriel, Geoffrey D. Hugo, Kuo-Chan Weng, Nathaniel Huebsch, Julie K. Schwarz, Bo Zhang, Stacey L. Rentschler
View: Text | PDF
Research Article Cardiology Cell biology

Cardiac radiotherapy–induced epigenetic memory underlies electrophysiologic and metabolic reprogramming

  • Text
  • PDF
Abstract

Stereotactic arrhythmia radiotherapy (STAR) is emerging as a highly effective treatment for ventricular tachycardia (VT). Growing evidence indicates that STAR favorably reprograms the electrical substrate by speeding conduction and/or prolonging repolarization via modulation of ion channel expression, although the mechanisms by which single-fraction radiation mediates durable changes in gene expression are incompletely understood. Here, we identify dynamic changes in the cardiomyocyte epigenome and transcriptome after irradiation (IR) in vivo and in vitro, including durably increased expression and chromatin accessibility of Scn5a (encodes the α subunit of the sodium channel, NaV1.5), demonstrating a role for epigenetic memory in conduction velocity (CV) increases observed after STAR. Transcriptomic and epigenetic sequencing further identified dynamic changes in gene expression and regulatory regions involved in cellular repolarization, calcium handling, and metabolism after IR. These changes were mirrored by dose-dependent and cell-autonomous changes in repolarization, calcium flux, and mitochondrial respiration, highlighting important cellular processes that may mediate the therapeutic effects of STAR. Overall, we found that cardiomyocytes exposed to a single fraction of high-dose IR exhibited epigenetic reprogramming that mediated broad and dynamic physiologic responses.

Authors

Samuel D. Jordan, Shuhua Fu, Abigail Fulkerson, Donghua Hu, Sherwin Ng, David M. Zhang, Sneha Manikandan, Jeffrey Szymanski, Nan Hu, Yuqian Xie, Anish Bedi, James Tabor, Lauren Boggs-Bailey, Lori Strong, Stephanie Hicks, Lavanya Aryan, Nishanth Gabriel, Geoffrey D. Hugo, Kuo-Chan Weng, Nathaniel Huebsch, Julie K. Schwarz, Bo Zhang, Stacey L. Rentschler

×

Figure 3

IR induces cardiomyocyte-autonomous CV increases in a dose-dependent fashion in hiPSC-CM models.

Options: View larger image (or click on image) Download as PowerPoint
IR induces cardiomyocyte-autonomous CV increases in a dose-dependent fas...
(A) Tissue culture images of sham-treated and irradiated hiPSC-CMs 3 weeks after IR. Scale bar: 30 μm. (B) CV measurements assessed by MEA over time, shown as the CV and percentage of change in CV from day 0. Boxes represent the 25th–75th percentiles, and whiskers represent minimum-to-maximum values (nwells = 24 sham, 12 irradiated from 3 cryovials; 2-way ANOVA: Ptime, Ptreatment, and Pinteraction < 0.0001; Šídák’s post hoc test: *Padj = 0.030, **Padj = 0.005, ****Padj < 0.0001). (C) Western blots probed for NaV1.5, Cx43, and Na/K ATPase (loading control) from membrane preparations from sham-treated versus 25 Gy irradiated hiPSC-CMs 21 days after treatment. (D and E) FC in quantified density of NaV1.5 (D) and Cx43 (E) (n = 5 cryovials; 2-tailed t test: *PNaV1.5 = 0.014, PCx43 = 0.16). (F) Representative tissue culture images of sham-treated and 5, 15, and 25 Gy irradiated μEHTs 14 days after treatment. Scale bar: 1 mm. (G) Representative activation maps from optocardiography of sham-treated and 5, 15, and 25 Gy irradiated μEHTs 14 days after treatment. Tissues were stimulated at 1 Hz from the left knob. (H) Quantified CV in sham-treated versus 5, 15, and 25 Gy irradiated μEHTs 14 days after treatment, presented as the FC relative to the sham average by batch (≥22 μEHTs per condition from 5 differentiations; 1-way ANOVA: P = 0.0006; Tukey’s post hoc test: **Padj,sham–25Gy = 0.002, **Padj,5Gy–25Gy = 0.001).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts